ahlam1399
02-22-2016, 10:07 AM
Sa**fi says U.S. FDA accepts diabetes drug application
PARIS, Feb 22 (Reuters) - French drugmaker Sa**fi said the U.S. Food and Drug Administration (FDA) had accepted its application for the use of insulin and its lixisenatide drug in combination for the treatment of adults with Type 2 diabetes.
http://rc.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/rc/1/rc.htm)
http://rc.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/rc/2/rc.htm)
http://rc.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/a2.img (http://da.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/ach.img (http://adchoice.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/ach.htm)http://pi.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/a2t.imghttp://pi2.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4dc13c0f/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=x3WNBgynS1A:-_k4bz5vfXU:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=x3WNBgynS1A:-_k4bz5vfXU:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=x3WNBgynS1A:-_k4bz5vfXU:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=x3WNBgynS1A:-_k4bz5vfXU:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=x3WNBgynS1A:-_k4bz5vfXU:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/x3WNBgynS1A
PARIS, Feb 22 (Reuters) - French drugmaker Sa**fi said the U.S. Food and Drug Administration (FDA) had accepted its application for the use of insulin and its lixisenatide drug in combination for the treatment of adults with Type 2 diabetes.
http://rc.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/rc/1/rc.htm)
http://rc.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/rc/2/rc.htm)
http://rc.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/a2.img (http://da.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/ach.img (http://adchoice.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/ach.htm)http://pi.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/a2t.imghttp://pi2.feedsportal.com/r/247392322030/u/49/f/654213/c/35217/s/4dc13c0f/sc/19/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4dc13c0f/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=x3WNBgynS1A:-_k4bz5vfXU:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=x3WNBgynS1A:-_k4bz5vfXU:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=x3WNBgynS1A:-_k4bz5vfXU:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=x3WNBgynS1A:-_k4bz5vfXU:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=x3WNBgynS1A:-_k4bz5vfXU:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/x3WNBgynS1A